BioSpace News Archive

Kali, Inc. announced Frederick Ferri as the company’s new CEO. Mr. Ferri is the inventor of a patented cannabis extraction process.

PolarityTE, Inc. (Nasdaq: PTE), a commercial-stage biotechnology company focused on transforming the lives of patients by discovering, designing and developing a range of regenerative tissue products using a patient’s own tissue, and the University Hospitals Cleveland Medical Center jointly announced today that SkinTE™ is now available for use throughout the UH network of healthcare facilities.

Atkins Nutritionals, Inc. is kicking off 2019 with a new national advertising campaign, “Choose Wisely” that will continue to focus on educating consumers about making smart choices about the foods they eat, and avoiding excess carbohydrates and sugar

Athletico Physical Therapy has opened a new location in Lindenhurst on Tuesday, December 18th at 1870 E. Grand Ave., Lindenhurst, IL 60046.

Centene Corporation (NYSE: CNC) announced today it will present at the 37th Annual J. P. Morgan Healthcare Conference, to be held January 7-10, 2019, at the Westin St. Francis Hotel.

Designation recognizes products that bring improvements to the health care industry

Global Adaptation Skills Platform Aids Hospitals, Governments and Universities in Real-Life Interactions with Local Culture and Language Training

Eiger BioPharmaceuticals, Inc (Nasdaq:EIGR), focused on the development and commercialization of targeted therapies for rare and ultra-rare diseases, today announced that the Food and Drug Administration (FDA) has granted Breakthrough Therapy designation for lonafarnib for the treatment of Hutchinson-Gilford progeria syndrome (HGPS or Progeria) and progeroid laminopathies.

Cocaine positivity increases nearly 43 percent in Retail, more than twice the overall increase of the general U.S. workforce

Auron Therapeutics and Elucidata Corporation announced a scientific collaboration using Elucidata’s AI-based target discovery platform to identify and validate targets for differentiation9-based therapy for Acute Myeloid Leukemia (AML) and eight other oncology indications